Urbanucci, Alfonso
https://orcid.org/0000-0003-2931-3652 Tutkimustoiminnan kuvaus
Dr Alfonso Urbanucci graduated from the University of Perugia, in Italy, and got his PhD in cancer genetics and molecular biology of cancer in Finland, at the University of Tampere, in 2012. Currently, Dr Alfonso Urbanucci is a Senior Research Fellow of the Tampere Institute of Advanced Study. He is the group leader of the “Genomic Regulation for Precision Cancer Medicine Lab” within the Prostate Cancer Research Center at the Faculty of Medicine and Health Technology. He is also a project group leader and principal investigator at the Department of Tumor Biology, Institute for Cancer Research within the Oslo University Hospital, and Associate Investigator of the Norwegian Center for Molecular Medicine (EMBL partnership). Dr Urbanucci researches prostate cancer using models and clinical specimens to understand the role of the prostate tumor immune microenvironment and of immune cells in shaping tumor behavior. Further, the goal of the research is to promote the use of transcriptional signatures derived from studies of single cells as a footprint for characterizing the tumor ability to relapse and inform clinical decision making in prostate cancer patients.Affiliaatiot
Tampere University
Lähde: ORCID
Lähde: ORCID
Nimike
Group Leader 2022 -
Oslo Universitetssykehus
Yksikkö
Tumor Biology
Lähde: ORCID
Nimike
Principal Investigator, Project Group Leader 2018 -
Julkaisut (63)
Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
2024
Data from Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
2023
Data from Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
2023
Rahoitusmyönnöt (2)
Aktiviteetit ja palkinnot (9)
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancermuu aktiviteetti2021